Cited by 831Genomics and Rare DiseasesConnective tissue disorders researchHereditary Neurological Disorders

Improving genetic diagnosis in Mendelian disease with transcriptome sequencing

Open access
Cummings, Beryl B., Marshall, Jamie L., Tukiainen, Taru, Lek, Monkol, Donkervoort, Sandra, Foley, A. Reghan, Bolduc, Veronique, Waddell, Leigh B. +31 more·2017·Science Translational Medicine

Published version of a preprint

Abstract

Transcriptome sequencing improves the diagnostic rate for Mendelian disease in patients for whom genetic analysis has not returned a diagnosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aal5209

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous studies have reported that RNA-Seq helps interpret VUSs identified through WES/WGS when linked to an aberrant transcript event, and detects variants missed by current standard diagnostic approaches in rare diseases.

    “Previous studies have reported that RNA-Seq helps interpret VUSs identified through WES/WGS when linked to an aberrant transcript event, and detects variants missed by current standard diagnostic approaches in rare diseases [42,45,46].”
  • Direct functional genomic exploration of accessible and disease-relevant tissues from patients using RNA sequencing and DNA methylation assays can identify previously cryptic causal genetic variants, particularly in under-explored noncoding regions.

    “Direct functional genomic exploration of accessible and disease-relevant tissues from patients using RNA sequencing and DNA methylation assays30,31 can identify previously cryptic causal genetic variants, particularly in under-explored regions outside protein-coding genes32,33.”

    From A brief history of human disease genetics (2020) · cites this paper as [30]

  • Deep sequencing of affected tissues for mosaic variants and RNA sequencing for noncoding variants are new fronts in clinical diagnostics.

    “Deep sequencing of affected tissues for mosaic variants and the use of RNA sequencing to detect noncoding variants that drive early-onset disease (for example, through effects on splicing) represent new fronts for clinical diagnostics30.”

    From A brief history of human disease genetics (2020) · cites this paper as [30]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cummings, B. B., Marshall, J. L., Tukiainen, T., Lek, M., Donkervoort, S., Foley, A. R., Bolduc, V., Waddell, L. B., Sandaradura, S. A., O’Grady, G. L., Estrella, E., Reddy, H. M., Zhao, F., Weisburd, B., Karczewski, K. J., O’Donnell-Luria, A. H., Birnbaum, D., Sarkozy, A., Hu, Y., Gonorazky, H., Claeys, K., Joshi, H., Bournazos, A., Oates, E. C., Ghaoui, R., Davis, M. R., Laing, N. G., Topf, A., Genotype-Tissue Expression Consortium, Kang, P. B., Beggs, A. H., North, K. N., Straub, V., Dowling, J. J., Muntoni, F., Clarke, N. F., Cooper, S. T., Bönnemann, C. G., & MacArthur, D. G.
Affiliations
  • Broad Institute (US)
  • National Institutes of Health (US)
  • Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • The University of Sydney (AU)
  • Boston Children's Hospital (US)
  • University of Florida Health (US)
  • Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Dubowitz Neuromuscular Centre, University College London Institute of Child Health, London WC1N 1EH, U.K.
  • Hospital for Sick Children (CA)
  • Universitair Ziekenhuis Leuven (BE)
  • Pathwest Laboratory Medicine (AU)
  • The University of Western Australia (AU)
  • John Walton Muscular Dystrophy Research Centre, MRC (Medical Research Council) Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, U.K.
  • Royal Children's Hospital (AU)
Corresponding author
MacArthur, Daniel G.
Venue
Science Translational Medicine
Published
2017-04-19
Volume
9
Issue
386
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2949444664
Cited by
831
References
49
Citations by year
2026: 66 · 2025: 59 · 2024: 81 · 2023: 76 · 2022: 110 · 2021: 114 · 2020: 124 · 2019: 101 · 2018: 67 · 2017: 27 · 2016: 1 · 2014: 1 · 2013: 1
FWCI
57.94
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Lirias (submittedVersion)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Broad Institute (Broad Ignite)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
monogenic disorders, genetic diagnosis, transcriptome sequencing, triple-helical domain, rare diseases, pathogenic variant identification, variant interpretation
MeSH terms
Humans, Muscular Diseases, Mutation, Collagen Type VI, High-Throughput Nucleotide Sequencing, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review